Pharmacokinetics of azlocillin in neonates

Area of Science:

• Pharmacology
• Pediatric Infectious Diseases
• Antibiotic Pharmacokinetics

Background:

• Azlocillin is an acylureido-penicillin antibiotic used for bacterial infections.
• Understanding the pharmacokinetics of antibiotics in infants is crucial for effective treatment.
• Neonatal and pediatric populations often require specific dosing adjustments due to physiological differences.

Purpose of the Study:

• To determine the pharmacokinetics of azlocillin in premature and full-term infants.
• To establish effective and safe dosing regimens for azlocillin in these pediatric populations.
• To evaluate the safety profile of azlocillin in infants.

Main Methods:

• Pharmacokinetic study involving intravenous and intramuscular administration of azlocillin.
• Inclusion of 53 premature and full-term infants diagnosed with infections.
• Monitoring of drug concentrations to determine effective levels.

Main Results:

• Effective azlocillin concentrations were achieved in premature infants at 50 mg/kg every 12 hours.
• Effective azlocillin concentrations were achieved in full-term infants at 100 mg/kg every 12 hours.
• No adverse effects associated with azlocillin administration were observed in the study population.

Conclusions:

• A reliable dosage schedule for azlocillin has been established for premature and full-term infants.
• Azlocillin demonstrates favorable pharmacokinetics and a good safety profile in the studied infant populations.
• The established dosage regimens can guide the treatment of infections in neonates and infants with azlocillin.